COMPUGROUP MEDICAL NORWAY AS

1366 LYSAKER

Finances

Share Ownership

Return on Equity

68,15 %

Current Ratio

1,76

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	115 677 000	114 003 000	107 599 000	95 493 000
Net Income	25 281 000	24 865 000	24 922 000	20 902 000
Total Assets	84 283 000	84 651 000	101 394 000	77 775 000
Total Equity	37 096 000	37 015 000	36 950 000	36 928 000

Income (NOK)	2022	2021	2020	2019
Revenue	115 677 000	114 003 000	107 599 000	95 493 000
Expenditure	63 738 000	62 417 000	57 025 000	52 174 000
Operating Profit	31 352 000	31 255 000	30 867 000	24 943 000
Financial Income	1 078 000	628 000	1 093 000	1 867 000
Financial Costs	6 000	3 000	4 000	0
Financial Balance	1 072 000	625 000	1 089 000	1 867 000
Earnings Before Tax	32 423 000	31 880 000	31 956 000	26 810 000
Tax	7 142 000	7 015 000	7 034 000	5 908 000
Net Income	25 281 000	24 865 000	24 922 000	20 902 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 196 000	1 625 000	1 098 000	1 688 000
Total Current Assets	83 087 000	83 026 000	100 296 000	76 087 000
Total Assets	84 283 000	84 651 000	101 394 000	77 775 000
Total Retained Equity	34 596 000	34 515 000	34 450 000	34 428 000
Total Equity	37 096 000	37 015 000	36 950 000	36 928 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	47 186 000	47 636 000	64 445 000	40 847 000
Total Equity and Debt	84 283 000	84 651 000	101 394 000	77 775 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	114 099 000	111 812 000	105 729 000	92 754 000
Other Income	1 578 000	2 191 000	1 870 000	2 739 000
Revenue	115 677 000	114 003 000	107 599 000	95 493 000
Cost of Goods Sold	0	0	0	0
Salary Costs	39 724 000	40 690 000	37 026 000	36 486 000
Depreciation	507 000	339 000	966 000	1 931 000
Impairment	0	0	0	0
Expenditure	63 738 000	62 417 000	57 025 000	52 174 000
Operating Profit	31 352 000	31 255 000	30 867 000	24 943 000
Financial Income	1 078 000	628 000	1 093 000	1 867 000
Financial Costs	6 000	3 000	4 000	0
Financial Balance	1 072 000	625 000	1 089 000	1 867 000
Dividends	25 200 000	24 800 000	24 900 000	13 000 000
Net Income	25 281 000	24 865 000	24 922 000	20 902 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	507 000	608 000	576 000	1 453 000
Real Eastate	689 000	1 016 000	523 000	235 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	689 000	1 016 000	523 000	235 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 196 000	1 625 000	1 098 000	1 688 000
Stock	0	0	19 000	16 000
Total Investments	0	0	0	0
Cash, Bank	20 280 000	61 673 000	0	0
Total Current Assets	83 087 000	83 026 000	100 296 000	76 087 000
Total Assets	84 283 000	84 651 000	101 394 000	77 775 000
Total Equity	37 096 000	37 015 000	36 950 000	36 928 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	6 658 000	6 821 000	13 502 000	5 290 000
Unpaid Taxes	5 688 000	5 454 000	6 671 000	6 167 000
Dividends	25 200 000	24 800 000	24 900 000	13 000 000
Other Current Debt	2 600 000	3 513 000	12 414 000	10 673 000
Total Current Debt	47 186 000	47 636 000	64 445 000	40 847 000
Total Equity and Debt	84 283 000	84 651 000	101 394 000	77 775 000

Financial indicators	2022	2021	2020	2019
Return on Equity	68,15 %	67,18 %	67,45 %	56,6 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	27,1 %	27,42 %	28,69 %	26,12 %
Current Ratio	1,76	1,74	1,56	1,86
Quick Ratio	1,76	1,74	1,56	1,86
Equity Ratio	0,44	0,44	0,36	0,47
Gross Profit Margin	100 %	100 %	100 %	100 %